Advanced breast cancer with ultra-low HER2 expression

Clinical trials for Advanced breast cancer with ultra-low HER2 expression explained in plain language.

Never miss a new study

Get alerted when new Advanced breast cancer with ultra-low HER2 expression trials appear

Sign up with your email to follow new studies for Advanced breast cancer with ultra-low HER2 expression, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a targeted drug reach breast cancers that test 'Too Low' for HER2 therapy?

Disease control Recruiting now

Researchers are testing an experimental drug called SHR-A1811 in 30 women with advanced breast cancer whose tumors show ultra-low HER2 expression, a level that usually falls below the cutoff for existing HER2-targeted treatments. Participants receive the drug by intravenous infus…

Matched conditions: ADVANCED BREAST CANCER WITH ULTRA-LOW HER2 EXPRESSION

Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Sep 16, 2026 00:00 UTC

Advanced breast cancer with ultra-low HER2 expression

Get alerted when new Advanced breast cancer with ultra-low HER2 expression trials appear

Can a targeted drug reach breast cancers that test 'Too Low' for HER2 therapy?